This study will evaluate the long-term safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal atrial fibrillation.
A diagnosis of recurrent symptomatic paroxysmal atrial fibrillation
Failure or intolerance of at least one antiarrhythmic drug (AAD) Class I or III
Persistent or long-standing persistent atrial fibrillation (continuous atrial fibrillation that is sustained >12 months)
Atrial fibrillation secondary to a reversible cause or of non-cardiac origin
History of thromboembolic events within the past six months
Myocardial infarction (MI)/percutaneous coronary intervention (PCI) within the last three months